The contribution of cholinergic dysfunction to the non-mnestic cognitive impairments associated with senile dementia of the Alzheimer type (SDAT) was investigated. Scopolamine (0 . 5 mg) was administered intravenously to 12 healthy individuals, and their performance on selected subtests of the Wechs
Cognitive functions affected by scopolamine in alzheimer's disease and normal aging
β Scribed by Dr. F. Jacob Huff; Susan F. Mickel; Suzanne Corkin; John H. Growdon
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 536 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Depression is very common in patients with dementia but the relationship is very complex. Depression is regarded as a cause of excess disability in persons with dementia and contributes to their functional decline. The assessment of depression in dementia patients, however, has been dif
## Abstract ## Background Stroke risk factors have been increasingly implicated in the development of ageβrelated cognitive decline, the spectrum of vascular cognitive impairment, and, more recently, Alzheimer's disease (AD). In addition, depression and the apolipoprotein (APOE) Ξ΅4 allele have bee